National Clinical Guideline - Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease

The NCCP has published a National evidence-based Clinical Guideline.

You can download this guideline in PDF format (1.21MB) HERE.

A summary of the guideline is also available in PDF format (660KB) HERE.

Information on the National Gestational Trophoblastic Disease Registry Monitoring and Advisory Centre can be found HERE.

You can download the literature search strategies for this guideline in PDF format (281KB) HERE.

Evidence-based guidelines:

  • Aim to improve the quality of clinical care,
  • Aim to prevent variation in practice,
  • Aim to address areas of clinical care with new and emerging evidence,
  • They are based on the best research evidence in conjunction with clinical expertise,
  • They are developed using a clear evidence-based internationally used methodology.

A Guideline Development Group was responsible for the development of this National Clinical Guideline and included representatives from relevant professional groups. The guideline focuses on the diagnosis, staging and treatment of patients with breast cancer. It does not include recommendations covering every aspect of diagnosis, staging and treatment. Instead this guideline focuses on areas of clinical practice:

  • known to be controversial or uncertain,
  • where there is identifiable variation in practice,
  • where there is new or emerging evidence,
  • where guidelines have potential to have the most impact.

This evidence-based clinical guideline will ensure standardised multidisciplinary care for patients, putting evidence into practice to improve patient outcomes.

Comments should be emailed to

(note on page 8 of this guideline, reference is made to accompanying documents - not all of these are available on the website yet and will be uploaded shortly)

Last updated: 24th September 2018